Speaker illustration

Professor Dobromir Dobrev

University Hospital of Essen (Ruhr), Essen (Germany)

Member of:

European Society of Cardiology
European Heart Rythm Association
Heart Failure Association

Dr. Dobrev is Full Professor and Director of Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany. He also serves as Adjunct Full Professor of Medicine at Montreal Heart Institute, University of Montreal, Canada and Baylor College of Medicine, Houston, USA. His main research interest is the molecular basis of disease-related cardiac remodeling and arrhythmias and identification and validation of novel antiarrhythmic targets. Dr. Dobrev is recognized nationally and internationally as an expert in cardiovascular research.

Insight into atrial physiology and pathology

Event: ESC CONGRESS 2019

Topic: Arrhythmias

Session type: Moderated Posters

Thumbnail

Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Event: EHRA 2019

Topic: Arrhythmias

Session type: New ESC Guidelines

Thumbnail

Molecular basis for arrhythmias and beyond

Event: Frontiers in CardioVascular Biology 2018

Topic: Cardiac Biology and Physiology

Session type: Featured Symposium

Thumbnail

Atrial cardiomyopathy and fibrillation

Event: EHRA 2018

Topic: Atrial Fibrillation - Pathophysiology and Mechanisms

Session type: Symposium

Thumbnail

Cardiovascular development, anatomy and pathology

Event: ESC CONGRESS 2017

Topic: Cardiovascular anatomy and pathology

Session type: Rapid Fire Abstracts

Thumbnail

Carmeliet-Coraboeuf-Weidmann lecture

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Cellular Electrophysiology

Session type: Symposium

Thumbnail

Novel targets in arrhythmias

Event: ESC CONGRESS 2016

Topic: Ion channels and electrophysiology

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk